Clinical Trial Update: A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer [Phase 1]

View source ↗

Summary

This Phase 1 trial investigates changes in PD-L1 expression during preoperative therapy with nab-paclitaxel and pembrolizumab in hormone receptor-positive breas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Adrienne G. Waks | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED | Results posted: 2024-09-20